BACKGROUND: The Colorectal Cancer and Home-Based Physical Exercise (CAN-HOPE) trial compared the effects of a 16-week home-based exercise program to usual care on quality of life in colorectal cancer survivors. PURPOSE: In this study, we report the weekly exercise barriers from the exercise group. METHODS: Participants randomized to the exercisegroup (N = 69) were asked to report their exercise on a weekly basis by telephone. Those participants not achieving the minimum weekly exercise prescription (3 times per week of 30 min of moderate intensity exercise) were asked for a primary exercise barrier. RESULTS: We obtained 1,073 (97.2%) weeks of adherence data out of a possible 1,104 (i.e., 69 x 16). Participants did not meet the minimum exercise prescription in 39.2% (421/1,073) of the weeks. We obtained an exercise barrier in 83.8% (353/421) of these cases. Overall, participants reported 37 different exercise barriers; the three most common were lack of time/too busy, nonspecific treatment side effects, and fatigue. The top 7 to 10 barriers accounted for 70% to 80% of all missed exercise weeks. CONCLUSIONS: These findings may have utility for promoting exercise in this population both inside and outside of clinical trials.
RCT Entities:
BACKGROUND: The Colorectal Cancer and Home-Based Physical Exercise (CAN-HOPE) trial compared the effects of a 16-week home-based exercise program to usual care on quality of life in colorectal cancer survivors. PURPOSE: In this study, we report the weekly exercise barriers from the exercise group. METHODS:Participants randomized to the exercise group (N = 69) were asked to report their exercise on a weekly basis by telephone. Those participants not achieving the minimum weekly exercise prescription (3 times per week of 30 min of moderate intensity exercise) were asked for a primary exercise barrier. RESULTS: We obtained 1,073 (97.2%) weeks of adherence data out of a possible 1,104 (i.e., 69 x 16). Participants did not meet the minimum exercise prescription in 39.2% (421/1,073) of the weeks. We obtained an exercise barrier in 83.8% (353/421) of these cases. Overall, participants reported 37 different exercise barriers; the three most common were lack of time/too busy, nonspecific treatment side effects, and fatigue. The top 7 to 10 barriers accounted for 70% to 80% of all missed exercise weeks. CONCLUSIONS: These findings may have utility for promoting exercise in this population both inside and outside of clinical trials.
Authors: Erin L McGowan; Amy E Speed-Andrews; Ryan E Rhodes; Chris M Blanchard; S Nicole Culos-Reed; Christine M Friedenreich; Kerry S Courneya Journal: Support Care Cancer Date: 2012-05-26 Impact factor: 3.603
Authors: Emily E Ventura; Patricia A Ganz; Julienne E Bower; Liana Abascal; Laura Petersen; Annette L Stanton; Catherine M Crespi Journal: Breast Cancer Res Treat Date: 2013-11-01 Impact factor: 4.872
Authors: Meredith A Wampler; Mary Lou Galantino; Sujuan Huang; Laura S Gilchrist; Victoria G Marchese; G Stephen Morris; David A Scalzitti; Melissa M Hudson; Kevin C Oeffinger; Marilyn Stovall; Wendy M Leisenring; Gregory T Armstrong; Leslie L Robison; Kirsten K Ness Journal: J Cancer Surviv Date: 2011-06-18 Impact factor: 4.442
Authors: David J Harriss; N Tim Cable; Keith George; Thomas Reilly; Andrew G Renehan; Najib Haboubi Journal: Sports Med Date: 2007 Impact factor: 11.136